In the latest issue! Memory B cell fitness and anergy has significant links to cancer lethality dlvr.it/TCPZpl

Nature research paper: Fate induction in CD8 CAR T cells through asymmetric cell division go.nature.com/4g6YAyU

We are excited to announce our $325 million #SeriesC financing. This new investment will enable ArsenalBio's ongoing development efforts and scale our manufacturing capabilities to develop T-cell medicines. We thank the new investors along with our existing investors for their

In case you missed it: Sophie Guelfi (蒙阴/蒙阴兼职/蒙阴上门/蒙阴资源/蒙阴线下/蒙阴同城/蒙阴学生), Kairbaan Hodivala-Dilke (Hodivala-Dilke Lab) and Gabriele Bergers (BergersLab) discuss possibilities to target the #TumourVasculature as part of combination therapies. go.nature.com/4dROuQW

Distinct epigenomic landscapes underlie tissue-specific memory T cell differentiation dlvr.it/TD92S6

Now online! Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy dlvr.it/TDF4WJ

BCG vaccination alters the epigenetic landscape of progenitor cells in human bone marrow to influence innate immune responses dlvr.it/TDG8Cr

Online now: Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma dlvr.it/TDGcvv

New research shows that disrupting the Asxl1 gene in T cells boosts response to immunotherapy and improves long-term tumor control by preventing T-cell exhaustion. Targeting Asxl1 may lead to more effective T cell-based immunotherapies. ow.ly/QbIg50TJeVq

In a new Science study, researchers undertook a reverse-translation approach to investigate the molecular mechanisms regulating the durability of #Tcell responsiveness to checkpoint blockade immunotherapy. 📃: bit.ly/4dQ5TJ9 #SciencePerspective: bit.ly/4dITlTD

An engineered T cell (center) is designed to deliver therapies to the brain. This T cell displays orange synthetic receptors on its surface, which recognize components of extracellular matrix fibers that are only found in the brain. Within the cell, downstream signaling pathways

St. Jude scientists leveraged findings about how cancer cells reduce the effectiveness of immunotherapy to suggest a combination treatment to reduce leukemia relapse. Read more: ow.ly/VhTj50V69eE